[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA201270269A1 - Фармацевтическая таблетка, содержащая розувастатин кальция - Google Patents

Фармацевтическая таблетка, содержащая розувастатин кальция

Info

Publication number
EA201270269A1
EA201270269A1 EA201270269A EA201270269A EA201270269A1 EA 201270269 A1 EA201270269 A1 EA 201270269A1 EA 201270269 A EA201270269 A EA 201270269A EA 201270269 A EA201270269 A EA 201270269A EA 201270269 A1 EA201270269 A1 EA 201270269A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rosuvastatin calcium
tablet containing
pharmaceutical tablet
containing rosuvastatin
tablet
Prior art date
Application number
EA201270269A
Other languages
English (en)
Inventor
Марта Виванкос
Original Assignee
Синтон Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синтон Б.В. filed Critical Синтон Б.В.
Publication of EA201270269A1 publication Critical patent/EA201270269A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение относится к таблетке, которая включает в себя i) прессованное ядро, содержащее розувастатин кальция, двухосновный фосфат кальция и по меньшей мере один фармацевтически приемлемый эксципиент, и ii) влагонепроницаемый слой вокруг упомянутого ядра, содержащий поливиниловый спирт, к способу изготовления данной таблетки и использованию ее в медицине.
EA201270269A 2009-08-13 2010-07-29 Фармацевтическая таблетка, содержащая розувастатин кальция EA201270269A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23354209P 2009-08-13 2009-08-13
PCT/EP2010/004796 WO2011018185A2 (en) 2009-08-13 2010-07-29 Pharmaceutical tablet comprising rosuvastatin calcium

Publications (1)

Publication Number Publication Date
EA201270269A1 true EA201270269A1 (ru) 2012-09-28

Family

ID=43334705

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270269A EA201270269A1 (ru) 2009-08-13 2010-07-29 Фармацевтическая таблетка, содержащая розувастатин кальция

Country Status (4)

Country Link
EP (1) EP2464344A2 (ru)
AU (1) AU2010281913A1 (ru)
EA (1) EA201270269A1 (ru)
WO (1) WO2011018185A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO129060B1 (ro) * 2013-04-25 2014-11-28 Antibiotice S.A. Compoziţie farmaceutică stabilă cu rosuvastatină calcică amorfă
CN104473899B (zh) * 2014-12-19 2017-10-03 河南润弘制药股份有限公司 一种瑞舒伐他汀钙片剂及其制备方法
MX2019005572A (es) * 2016-11-15 2019-08-14 Lg Chemical Ltd Complejo medicinal para tratar diabetes tipo 2 y dislipidemia diabetica.
GB2622822A (en) 2022-09-28 2024-04-03 Novumgen Ltd A rapidly disintegrating tablet of rosuvastatin and its process of preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
MXPA05005813A (es) * 2002-12-20 2005-12-12 Pfizer Prod Inc Formas de dosificacion que comprenden un inhibidor de la cetp y un inhibidor de la hmg-coa reductasa.
EP1844021A1 (en) * 2005-01-31 2007-10-17 Ciba Specialty Chemicals Holding Inc. Crystalline forms of rosuvastatin calcium salt
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof

Also Published As

Publication number Publication date
WO2011018185A2 (en) 2011-02-17
WO2011018185A3 (en) 2011-11-24
AU2010281913A1 (en) 2012-04-05
EP2464344A2 (en) 2012-06-20

Similar Documents

Publication Publication Date Title
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
MX350875B (es) Formas de dosificacion farmaceutica de liberacion controlada.
DK2445571T3 (da) Faste lægemiddeltabletter til implanterbare lægemiddelafgivelsesindretninger
WO2008146178A3 (en) A novel tablet dosage form
CL2011002858A1 (es) Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor.
CL2009000598A1 (es) Composicion farmaceutica oral que comprende particulas de liberacion pulsatil controlada en el tiempo (tpr), que contienen un farmaco poco soluble debilmente basico y un acido organico separados por una capa de liberacion sostenida, y particulas de liberacion rapida (rr); capsula que la comprende; y su uso para tratar emesis.
BR112012024139A2 (pt) formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
CY1110097T1 (el) Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων
MY149028A (en) Nalmefene hydrochloride dihydrate
IN2015DN04161A (ru)
CR20110704A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
EA200802324A1 (ru) Новая форма введения рацекадотрила
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
PH12014501408A1 (en) Immediate release multi unit pellet system
EA201270269A1 (ru) Фармацевтическая таблетка, содержащая розувастатин кальция
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
EA201171414A1 (ru) Ингибиторы белков семейства iap
IT1401284B1 (it) Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system).
UA105285C2 (ru) Твердая фармацевтическая лекарственная форма рамиприла и безилата амлодипина и ее получение
AR097202A1 (es) Composiciones farmacéuticas de ranolazina y dronedarona, procedimiento para elaborar tableta bicapa
GB0920721D0 (en) An orally administered anthelmintic unit dose tablet and process for the preparation thereof
CO6390099A2 (es) Tableta de liberación controlada de dosis baja
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью